Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
Phase of Trial: Phase III
Latest Information Update: 28 Jun 2010
At a glance
- Drugs Carbamazepine; Lithium; Olanzapine; Valproic acid
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Acronyms BMAC
- Sponsors Eli Lilly
- 09 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2008 Checked against the ClinicalTrials.gov record.
- 28 Sep 2008 Planned number of patients is now 143 according to the ClinicalTrials.gov record.